The increased emphasis on maintaining good air quality, especially after the covid pandemic, presents attractive tailwinds for the HVAC sector, Ardian’s North America team said following its recent ...

The Biden administration is looking to avoid the same hiccups experienced during the rollout of new COVID-19 vaccines as it begins shifting coverage of coronavirus treatments to the private market.

WASHINGTON, Oct 27 (Reuters) - Most people will retain access to Pfizer's (PFE.N), opens new tab Paxlovid and Merck's (MRK.N), opens new tab Lagevrio COVID-19 oral antiviral treatments for little or ...

Starting next month, SAG-AFTRA and the advertising industry will be putting an end to its vaccination directive for commercial projects. Since 2021, SAG-AFTRA has given commercial producers the right ...

New York businesses seeking to lure reluctant workers back to their offices encountered another obstacle toward the end of the summer as new coronavirus variants began to spread across the region. The ...

Just as with Covid-19 vaccines this season, the antiviral – a combination of the drugs nirmatrelvir and ritonavir – will move from being available free to everyone through government purchases to a ...

Pfizer will price a five-day course of its Covid antiviral drug Paxlovid at $1,390 when the company starts to sell it on the commercial market later this year. A company spokesperson on Wednesday ...

The U.S. government will stop distributing free doses of Merck & Co's COVID-19 antiviral treatment molnupiravir by the middle of next month and expects it to be sold on the commercial market instead.